tiprankstipranks
Trending News
More News >
Evolent Health (EVH)
NYSE:EVH
US Market

Evolent Health (EVH) Ratios

Compare
745 Followers

Evolent Health Ratios

EVH's free cash flow for Q4 2025 was $-0.04. For the 2025 fiscal year, EVH's free cash flow was decreased by $ and operating cash flow was $-0.88. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.31 1.31 0.85 1.01 1.10
Quick Ratio
1.31 1.31 0.85 1.01 1.10
Cash Ratio
0.39 0.39 0.15 0.29 0.43
Solvency Ratio
-0.28 -0.28 0.04 <0.01 0.07
Operating Cash Flow Ratio
0.10 0.10 0.03 0.21 -0.03
Short-Term Operating Cash Flow Coverage
0.00 2.53 0.11 0.00 0.00
Net Current Asset Value
$ -977.67M$ -977.67M$ -936.03M$ -928.93M$ -479.82M
Leverage Ratios
Debt-to-Assets Ratio
0.52 0.52 0.28 0.24 0.26
Debt-to-Equity Ratio
2.38 2.38 0.71 0.60 0.55
Debt-to-Capital Ratio
0.70 0.70 0.42 0.38 0.36
Long-Term Debt-to-Capital Ratio
0.70 0.70 0.33 0.36 0.32
Financial Leverage Ratio
4.57 4.57 2.54 2.51 2.11
Debt Service Coverage Ratio
-6.28 -4.96 0.44 1.19 5.59
Interest Coverage Ratio
-0.20 -0.08 -1.64 -1.31 0.23
Debt to Market Cap
3.07 2.16 0.51 0.16 0.16
Interest Debt Per Share
9.17 9.17 6.44 6.28 5.25
Net Debt to EBITDA
-2.32 -2.32 7.18 -18.24 6.58
Profitability Margins
Gross Profit Margin
15.09%15.09%14.38%23.45%23.42%
EBIT Margin
-25.43%-25.43%-1.50%-7.55%-3.44%
EBITDA Margin
-19.26%-19.26%3.32%-1.26%3.24%
Operating Profit Margin
-0.62%-0.24%-1.58%-3.63%0.27%
Pretax Profit Margin
-28.50%-28.50%-2.47%-10.31%-4.59%
Net Profit Margin
-28.49%-28.49%-2.41%-5.76%-1.42%
Continuous Operations Profit Margin
-28.49%-28.49%-2.41%-5.76%-1.38%
Net Income Per EBT
99.98%99.98%97.76%55.85%30.87%
EBT Per EBIT
4630.09%12057.65%155.70%284.23%-1704.48%
Return on Assets (ROA)
-28.14%-28.14%-2.42%-4.22%-1.05%
Return on Equity (ROE)
-69.22%-128.74%-6.15%-10.59%-2.23%
Return on Capital Employed (ROCE)
-0.76%-0.29%-2.21%-3.55%0.26%
Return on Invested Capital (ROIC)
-0.75%-0.29%-1.95%-1.97%0.08%
Return on Tangible Assets
-86.24%-86.24%-8.48%-13.93%-2.94%
Earnings Yield
-165.38%-117.00%-4.78%-3.08%-0.73%
Efficiency Ratios
Receivables Turnover
5.80 5.80 6.16 4.40 5.31
Payables Turnover
26.65 26.65 22.78 31.16 18.11
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
22.03 22.03 32.22 21.78 9.88
Asset Turnover
0.99 0.99 1.00 0.73 0.74
Working Capital Turnover Ratio
14.36 294.82 -51.64 72.68 21.97
Cash Conversion Cycle
49.22 49.22 43.22 71.32 48.60
Days of Sales Outstanding
62.91 62.91 59.25 83.03 68.76
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
13.69 13.69 16.02 11.71 20.15
Operating Cycle
62.91 62.91 59.25 83.03 68.76
Cash Flow Ratios
Operating Cash Flow Per Share
0.34 0.34 0.16 1.28 -0.12
Free Cash Flow Per Share
0.04 0.04 -0.05 1.02 -0.53
CapEx Per Share
0.30 0.30 0.22 0.26 0.41
Free Cash Flow to Operating Cash Flow
0.12 0.12 -0.33 0.80 4.32
Dividend Paid and CapEx Coverage Ratio
0.86 0.86 0.42 3.00 -0.30
Capital Expenditure Coverage Ratio
1.14 1.14 0.75 4.96 -0.30
Operating Cash Flow Coverage Ratio
0.04 0.04 0.03 0.22 -0.02
Operating Cash Flow to Sales Ratio
0.02 0.02 <0.01 0.07 >-0.01
Free Cash Flow Yield
1.51%1.04%-0.47%3.10%-1.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.60 -0.85 -20.94 -32.51 -137.29
Price-to-Sales (P/S) Ratio
0.17 0.24 0.51 1.87 1.95
Price-to-Book (P/B) Ratio
0.78 1.10 1.29 3.44 3.06
Price-to-Free Cash Flow (P/FCF) Ratio
66.44 96.07 -210.54 32.28 -52.71
Price-to-Operating Cash Flow Ratio
8.32 11.76 68.75 25.77 -227.74
Price-to-Earnings Growth (PEG) Ratio
<0.01 >-0.01 0.57 -0.06 3.09
Price-to-Fair Value
0.78 1.10 1.29 3.44 3.06
Enterprise Value Multiple
-3.19 -3.58 22.39 -166.50 66.73
Enterprise Value
1.15B 1.29B 1.90B 4.13B 2.92B
EV to EBITDA
-3.19 -3.58 22.39 -166.50 66.73
EV to Sales
0.61 0.69 0.74 2.10 2.16
EV to Free Cash Flow
242.65 272.28 -309.99 36.25 -58.48
EV to Operating Cash Flow
29.70 33.33 101.23 28.94 -252.66
Tangible Book Value Per Share
-7.57 -7.57 -7.12 -7.20 -3.27
Shareholders’ Equity Per Share
3.64 3.64 8.73 9.60 9.17
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 0.02 0.44 0.70
Revenue Per Share
16.43 16.43 22.28 17.65 14.43
Net Income Per Share
-4.68 -4.68 -0.54 -1.02 -0.20
Tax Burden
1.00 1.00 0.98 0.56 0.31
Interest Burden
1.12 1.12 1.65 1.37 1.33
Research & Development to Revenue
<0.01 0.00 0.00 0.00 0.02
SG&A to Revenue
0.04 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.02 0.02 0.02 0.03
Income Quality
-0.07 -0.07 -0.30 -1.26 0.60
Currency in USD